Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the ...
To add insult to injury, many hospitals that aggressively pursue unpaid medical bills profit from a federal drug discount program: the 340B Drug Pricing Program, which was established to help ...
Rescription, Inc., a leading innovator in pharmacy benefit management, is proud to announce it has been awarded a U.S.
Many believe the federal program limits healthcare organizations and hospitals from providing discounted medications.
The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...
Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and ...
The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...
Medicare’s Maximum Fair Price (MFP) officially went live on January 1st. Select Medicare Part D drugs are now subject to negotiated pricing under the Inflation Reduction Act, with 15 additional Part D ...
The federal government has been in a partial shutdown since late last week, with several federal agencies – including the U.S. Department of ...
Amgen Inc (AMGN) reports robust sales growth with 14 blockbuster products, while navigating competitive pressures and strategic pivots.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results